CRISPR screens identify the ATPase VCP as a druggable therapeutic vulnerability in cholangiocarcinoma

Yang Wu(Shanghai Jiao Tong University), Haojie Jin(Shanghai Cancer Institute)

Proceedings of the National Academy of Sciences

September 24, 2025

10.1073/pnas.2519568122

Cited by 1

Related Papers

Single‐Cell Transcriptomic Analysis Reveals a Hepatic Stellate Cell–Activation Roadmap and Myofibroblast Origin During Liver Fibrosis in Mice

|Hepatology|2021|229

Acidic extracellular pH induces autophagy to promote anoikis resistance of hepatocellular carcinoma cells via downregulation of miR-3663-3p

|Journal of Cancer|2021|38

Sustained activation of EGFR-ERK1/2 signaling limits the therapeutic response to tigecycline-induced inhibition of mitochondrial translation in liver cancer

|Research Square|2022|0